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Dear Sir,
B-cell chronic lymphocytic leukemia (B-CLL) is a neo-
plastic disease characterized by the proliferation of small
mature-appearing CD5+, CD23+ B-cells, which accumu-
late within the bone marrow, blood and lymphoid tis-
sues. 1,2 Extra-nodal involvement may be detected in sev-
eral organs but very few reports exist describing the
involvement of the orbit by B-CLL lymphocytes. 3,4,5 We
present the case of a 69-year-old man with B-CLL, who
developed orbital and periorbital infiltration by leukemia
cells at the same time that disease progressed and who
has been successfully treated with fludarabine.
In 1995, a 69-year-old-man was referred to our hospi-
tal for evaluation of a lymphocytosis detected on routine
blood analysis. The diagnosis of B-CLL, stage A of Binet
system, was made. Between 1995 and 1999, and
because the lymphocyte count doubled in less than 6
months, he was treated three times with pulses of chlo-
rambucil (0,15 mg/Kg/day, per os, 5 days) and pred-
nisolone (1 mg/Kg/day, per os, 5 days), in a total of 24
courses, and in all the three occasions a partial hemato-
logical response was obtained. By January 2000, the
patient presented with splenomegaly and bilateral
orbital masses. At that time, the physical examination
revealed smooth, non-tender masses near the superior
orbital rims, bilateral ptosis, diplopia and limited ocular
movements in all directions, especially on the left eye.
Computed tomography showed enlargement of all
extra-ocular muscles, upper and lower eyelids soft tissue
and lacrimal glands, preferentially on the left side, with-
out bony erosion (Figure 1). The orbital biopsy revealed
a dense infiltrate of small lymphocytes and flow cyto-
metric studies showed that 85% of them were CD19+,
CD20+low, CD22+low, CD5+, CD23+ and IgM/kappa+low B-
cells, a phenotype that was consistent with B-CLL and
identical to that observed in blood lymphocytes. By that
time the lymphocyte count was of 104.3x109/L, without
anemia or thrombocytopenia. Serum lactic dehydroge-
nase and beta-2 microglobulin levels were increased.
The patient was again treated with 8 courses of chlo-
rambucil and prednisone, with diminution of the tumor
masses and the lymphocyte count (4.9x109/L). Disease
progression occurred three months after therapy with-
draw, with clinical and laboratory findings similar to
those before the initial treatment. Afterwards, he under-
went treatment with fludarabine (40 mg/Kg/day, per os,
5 days, three courses). After fludarabine treatment, there
were no detectable orbital masses, the spleen was not
enlarged and the lymphocyte count decreased towards
8.8x109/L. The patient conditions remained unchanged
at last follow-up (3 months after finishing fludarabine
treatment), without evidence of disease progression,
either within the orbit or systemically. The patient
described here had periocular manifestations in the set-
ting of a worsening disease, and the identical tumor
markers in orbital and blood specimens confirmed
orbital infiltration by the same B-CLL clone that circulat-
ed in blood. There are several reports of involvement of
the orbit and adnexal structures and tissues throughout
the eye by leukemia and lymphoma cells, but these
structures are more involved in acute leukemia than in
chronic lymphoproliferative disorders. Orbital infiltra-
tion often presents as slowly enlarging lesions arising
from the eyelid, orbit, lacrimal gland or conjunctiva and
usually doesn’t compromise vision. In literature, the
extra-nodal involvement occurs in about 40% of
patients with non-Hodgkin`s lymphoma, and the orbit
accounts for 5-14% of all cases.6 Based on clinical
grounds, ocular and periocular involvement by B-CLL is
exceedingly rare, with only a few cases being described
in the literature to date; 3,4,5 it may occur as the initial
manifestation or develop during the disease course and
the possibility of local orbital recurrence should be con-
sidered.3,5 Conversely to the low frequency find in the
clinic, the results in autopsy studies for orbital involve-
ment reach 75%3. One of the explanations is the slow
growing rate of this kind of tumor, generally don’t giv-
ing symptoms unless it reaches a large size 1,2,6. Besides,
as there is no lymphatic connection between the orbits,
bilateral orbital involvement would suggest a degree of
site-specific homing.5,8 In contrast to the majority of pre-
vious reports of B-CLL involving the orbit our patient
had a diffuse infiltration of different structures of both
eyes, suggesting that B-CLL should be included in the
differential diagnosis of bilateral extra-ocular muscle
enlargment.3 The clinical benefice obtained with fludara-
bine therapy alone should be emphasized, because
orbital irradiation might result in severe ophthalmologic
complications.4
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